MedPath

Optimizing primary vaccination schedule for premature infants

Completed
Conditions
ational immunization program (NIP), preterm infants, immune response
Registration Number
NL-OMON21928
Lead Sponsor
Rijksinstituut voor Volksgezondheid en Milieu (RIVM)Antonie van Leeuwenhoeklaan 93721 BM Bilthoven030 - 274 91 11info@rivm.nlPostadres:Postbus 13720 BA Bilthoven
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Eligible for RIVAR study (This study is nested within an observational step-wedged cohort non-WMO study,RIVAR)

- Preterm infant (36 weeks of gestational age or younger).-

Exclusion Criteria

Not willing to take part in blood sampling

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath